bf/NASDAQ:AXGN_icon.jpeg

NASDAQ:AXGN

Axogen

  • Stock

16.48

+1.29%

1.58

USD last updated 15/08 02:20:07

Last Close

14.90

14/08 20:01

Market Cap

336.53M

Beta: 0.62

Volume Today

743.95K

Avg: 228.48K

PE Ratio

−18.28

PFCF: −17.18

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.25-0.2-0.15-0.1-0.052018-02-282020-02-242022-02-222023-11-072024-11-07

    Revenue (Estimate*)

    50M100M150M200M250M2018-02-282020-02-242022-02-222023-11-072024-11-07

    *Estimate based on analyst consensus